Skip to main content
. Author manuscript; available in PMC: 2024 Oct 13.
Published in final edited form as: Vaccine. 2023 Sep 14;41(43):6461–6469. doi: 10.1016/j.vaccine.2023.08.071

Figure 3. Mean genotypic SPVL of new infections over time under 90% coverage of a disease modifying vaccine with varying effects on phenotypic SPVL.

Figure 3.

Mean genotypic SPVL of all new infections at each time point (every 30 days) over 50 replicates. Shaded area reflects the 95% confidence interval.

Inset: focus on mean genotypic SPVL of new infections during year 30 after vaccine rollout, with bars indicating the 95% confidence interval